RANOLAZINE VERSUS PLACEBO IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY AND PERSISTENT CHEST PAIN OR DYSPNEA DESPITE OPTIMAL MEDICAL AND REVASCULARIZATION THERAPY: RANDOMIZED, DOUBLE-BLIND CROSSOVER PILOT STUDY

Ranolazine versus placebo in patients with ischemic cardiomyopathy and persistent chest pain or dyspnea despite optimal medical and revascularization therapy: randomized, double-blind crossover pilot study

Nicolas W Shammas,1 Gail A Shammas,1 Kathleen Keyes,2 Shawna Duske,1 Ryan Kelly,1 Michael Jerin3 1Midwest Cardiovascular Research Foundation, 2Cardiovascular Medicine, Private Corporation, 3St Ambrose University, Davenport, IA, USA 3 Teir Steamer Background: Patients with ischemic cardiomyopathy (ICM) may continue to experience persistent chest pai

read more


Consumption, liquidity constraint and welfare in Brazil

This paper investigates empirically what are the welfare gains of cycle smoothing in 3 Teir Steamer Brazil.We follow Lucas (1987) decomposing logarithmic aggregate consumption in a trend and a cycle, and then calculating what are the welfare gains of eliminating cyclical variability.Differently from Lucas, the trend component here is not determinis

read more